Feature Channels:

Clinical Trials

Add to Favorites Subscribe Share
Newswise: While Promoting Diseases Like Cancer, These Enzymes Also Cannibalize Each Other
  • Embargo expired:
    20-Jan-2020 3:00 PM EST

While Promoting Diseases Like Cancer, These Enzymes Also Cannibalize Each Other

Georgia Institute of Technology

In diseases like cancer, atherosclerosis, and sickle cell anemia, cathepsins promote their propagation. Drug trials to inhibit these enzymes have failed due to baffling side effects. Now a new study examines cathepsins in systems to remove some of the bafflement.

Channels: All Journal News, Grant Funded News, Blood, Cancer, Clinical Trials, Pharmaceuticals,

Released:
17-Jan-2020 10:05 AM EST
Newswise: Dozens of potential anti-cancer drugs netted in massive screening study
  • Embargo expired:
    20-Jan-2020 11:00 AM EST

Dozens of potential anti-cancer drugs netted in massive screening study

Dana-Farber Cancer Institute

A variety of existing drugs for treating conditions such as diabetes, inflammation, alcohol abuse, and arthritis in dogs can also kill cancer cells in the lab, according to a study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

Channels: All Journal News, Grant Funded News, Cancer, Clinical Trials, Pharmaceuticals, National Institutes of Health (NIH), Nature (journal),

Released:
19-Jan-2020 11:05 AM EST
Research Results

New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet

Georgetown Lombardi Comprehensive Cancer Center

Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance.

Channels: Clinical Trials, Liver Disease, Obesity, Pharmaceuticals, Weight Loss, National Institutes of Health (NIH), Grant Funded News,

Released:
20-Jan-2020 10:50 AM EST
Research Results
Newswise: Select few cancer patients enroll in potentially life-extending clinical trials

Select few cancer patients enroll in potentially life-extending clinical trials

Penn State College of Medicine

Patient enrollment in clinical trials as the first course of treatment after cancer diagnosis is low, despite the fact that enrollment may increase life expectancy, according to researchers at Penn State.

Channels: Cancer, Clinical Trials, Healthcare, All Journal News,

Released:
20-Jan-2020 9:55 AM EST
Research Results
mmc-logo.gif

Mayo Clinic تفحص تسلسل 100 ألف مشارك لبناء قاعدة بيانات للجينوم البشري لتحسين الرعاية والبحث بالتعاون مع Helix

Mayo Clinic

تقوم Mayo Clinic بإنشاء مكتبة من بيانات تسلسل الجينوم البشري بخصوص 100000 مشارك في Mayo Clinic تمت الموافقة عليهم من أجل النهوض بالبحوث ورعاية المرضى.

Channels: All Journal News, Clinical Trials, Genetics, Healthcare,

Released:
17-Jan-2020 11:15 AM EST
Research Results
TheOhioStateUniversity-4C-Stacked-CMYK.jpg

Acid reflux drugs may have negative side effects for breast cancer survivors

Ohio State University

Acid reflux drugs that are sometimes recommended to ease stomach problems during cancer treatment may have an unintended side effect: impairment of breast cancer survivors’ memory and concentration.

Channels: Cancer, Clinical Trials, Cognition and Learning, Digestive Disorders, Neuro, Pharmaceuticals, Women's Health, All Journal News, Staff Picks,

Released:
17-Jan-2020 10:25 AM EST
Announcement
Newswise: JAMA editorial helps set record straight on unproven sepsis therapy
  • Embargo expired:
    17-Jan-2020 6:30 AM EST

JAMA editorial helps set record straight on unproven sepsis therapy

University of Nebraska Medical Center (UNMC)

The Jan. 17 issue of the Journal of the American Medical Association (JAMA) features an important study about sepsis with an accompanying editorial by a University of Nebraska Medical Center expert. The study and editorial sets the record straight on an unproven therapy some physicians use to treat sepsis, a deadly infectious disease. The editorial, written by Andre Kalil, M.D., M.P.H., professor of infectious diseases in the UNMC Department of Internal Medicine, writes in support of the new and rigorous international study based on a randomized clinical trial in Australia, published in the same issue. The editorial appears in the Jan. 17 online issue and also will appear in the Feb. 4 print edition.

Channels: Clinical Trials, Healthcare, Infectious Diseases, Pharmaceuticals, JAMA, All Journal News, Blood,

Released:
16-Jan-2020 11:50 PM EST
Research Results
mmc-logo.gif

Mayo Clinic sequência 100 mil participantes para construir banco de dados genômico para melhor atendimento e pesquisa em colaboração com Helix

Mayo Clinic

A Mayo Clinic está criando uma biblioteca de dados de sequenciamento genômico de 100.000 participantes consentidos da Mayo Clinic para avançar na pesquisa e no atendimento ao paciente.

Channels: Clinical Trials, Genetics, Healthcare, Technology,

Released:
17-Jan-2020 12:05 AM EST
Policy
mmc-logo.gif

Mayo Clinic将携手Helix对10万名参与者进行基因组测序,以建立用于改善医疗和研究的基因组数据库

Mayo Clinic

Mayo Clinic正在着手创建一个基因组测序数据库以促进研究和改善患者治疗。该数据库将包含10万名参与者的基因组测序数据,Mayo Clinic已取得上述参与者的知情权。

Channels: Clinical Trials, Genetics, Healthcare, Technology,

Released:
16-Jan-2020 11:55 PM EST
Announcement
Newswise: Partnership with China Prompts Change in Care for High-Risk Type of Leukemia
  • Embargo expired:
    16-Jan-2020 11:00 AM EST

Partnership with China Prompts Change in Care for High-Risk Type of Leukemia

St. Jude Children's Research Hospital

Researchers from St. Jude Children’s Research Hospital and the Chinese Children’s Cancer Group led the first randomized, Phase III clinical trial comparing targeted therapies for acute lymphoblastic leukemia (ALL) driven by the Philadelphia chromosome. Results showed that the drug dasatinib provides more benefit than the standard of care, which led to changes in the way this leukemia is treated. The findings were reported today in JAMA Oncology.

Channels: Cancer, Children's Health, Clinical Trials, China News, Blood, JAMA, All Journal News,

Released:
14-Jan-2020 12:00 PM EST
Announcement


1.02667